Your browser is no longer supported. Please, upgrade your browser.
Settings
OPRX OptimizeRx Corporation daily Stock Chart
OPRX [NASD]
OptimizeRx Corporation
Index- P/E- EPS (ttm)-0.08 Insider Own1.00% Shs Outstand11.92M Perf Week-17.75%
Market Cap166.28M Forward P/E97.55 EPS next Y0.14 Insider Trans- Shs Float7.19M Perf Month-19.60%
Income-0.80M PEG- EPS next Q-0.01 Inst Own37.50% Short Float1.11% Perf Quarter11.51%
Sales16.30M P/S10.20 EPS this Y-37.80% Inst Trans9.32% Short Ratio1.50 Perf Half Y74.37%
Book/sh1.46 P/B9.55 EPS next Y429.63% ROA- Target Price23.33 Perf Year210.00%
Cash/sh1.13 P/C12.32 EPS next 5Y50.00% ROE- 52W Range3.36 - 18.39 Perf YTD196.18%
Dividend- P/FCF- EPS past 5Y-17.40% ROI-34.40% 52W High-24.14% Beta0.42
Dividend %- Quick Ratio7.40 Sales past 5Y43.60% Gross Margin54.50% 52W Low315.14% ATR1.29
Employees23 Current Ratio7.40 Sales Q/Q248.40% Oper. Margin- RSI (14)34.64 Volatility7.25% 7.71%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.39 Prev Close14.00
ShortableYes LT Debt/Eq0.00 EarningsNov 05 AMC Payout0.00% Avg Volume53.22K Price13.95
Recom2.00 SMA20-14.70% SMA50-14.44% SMA20040.08% Volume20,687 Change-0.36%
Nov-16-18 07:37AM  Do Institutions Own OptimizeRx Corporation (NASDAQ:OPRX) Shares? Simply Wall St.
Nov-15-18 08:40AM  Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -7.83%
Nov-07-18 08:31AM  OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16 GlobeNewswire +9.39%
Nov-06-18 01:10AM  Edited Transcript of OPRX earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-05-18 04:01PM  OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS GlobeNewswire
Oct-29-18 10:31AM  OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For Zacks
Oct-25-18 11:52AM  OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018 GlobeNewswire
Oct-23-18 08:31AM  OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ET GlobeNewswire
Oct-17-18 08:30AM  OptimizeRx Acquires CareSpeak Communications GlobeNewswire +10.19%
Oct-11-18 08:23AM  Are OptimizeRx Corporations (NASDAQ:OPRX) Interest Costs Too High? Simply Wall St. -7.85%
Oct-10-18 08:31AM  OptimizeRx Invited to Co-Host Plenary Session at Digital Pharma East on October 17, 2018 GlobeNewswire -14.43%
Oct-09-18 08:30AM  MicroCap Review Magazine Fall 2018 Issue Now Available ACCESSWIRE
Oct-08-18 09:44AM  Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings Zacks
Oct-05-18 07:48AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Sep-27-18 08:31AM  OptimizeRx Partners with Medicom Health to Bring Automated Medication Savings Directly to Patients at Hospitals Nationwide GlobeNewswire
Sep-12-18 09:00AM  OptimizeRx Launches ROI Guarantee to Pharmaceutical Manufacturers GlobeNewswire
Aug-29-18 08:31AM  OptimizeRx to Participate at Lake Street Capital Markets Best Ideas Growth Conference on September 13, 2018 GlobeNewswire
Aug-21-18 01:50PM  Edited Transcript of OPRX earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria. The company's products and applications also comprise brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. It has a strategic partnership with Patient Connect to deliver real-time messaging at point-of-care in Europe. OptimizeRx Corporation is based in Rochester, Michigan.